Elisa Biscaldi

705 total citations
3 papers, 38 citations indexed

About

Elisa Biscaldi is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Elisa Biscaldi has authored 3 papers receiving a total of 38 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Cancer Research and 1 paper in Molecular Biology. Recurrent topics in Elisa Biscaldi's work include Pancreatic and Hepatic Oncology Research (1 paper), Angiogenesis and VEGF in Cancer (1 paper) and Cancer Genomics and Diagnostics (1 paper). Elisa Biscaldi is often cited by papers focused on Pancreatic and Hepatic Oncology Research (1 paper), Angiogenesis and VEGF in Cancer (1 paper) and Cancer Genomics and Diagnostics (1 paper). Elisa Biscaldi collaborates with scholars based in Italy, Singapore and Argentina. Elisa Biscaldi's co-authors include Valentina Tibollo, Raffaella Palumbo, Federico Sottotetti, Mara Frascaroli, Erica Quaquarini, Antônio Bernardo, Luca Mollica, Daniele Presti, Cristina Teragni and Alberto Malovini and has published in prestigious journals such as Journal of Clinical Oncology, Cancers and Oncology Reports.

In The Last Decade

Elisa Biscaldi

3 papers receiving 38 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elisa Biscaldi Italy	3	27	9	8	7	7	3	38
Elisabeth Stöhr Germany	3	27 1.0×	5 0.6×	10 1.3×	11 1.6×	5 0.7×	3	39
Alexa Gillman United Kingdom	4	15 0.6×	15 1.7×	12 1.5×	2 0.3×	16 2.3×	9	90
Claudio Lombardo Italy	7	26 1.0×	21 2.3×	10 1.3×	4 0.6×	19 2.7×	16	92
Joseph Joseph Australia	5	27 1.0×	2 0.2×	10 1.3×	3 0.4×	6 0.9×	11	87
Nagabhishek Moka United States	3	45 1.7×	4 0.4×	4 0.5×	3 0.4×	7 1.0×	11	63
Zahra Ravankhah Iran	3	14 0.5×	6 0.7×	3 0.4×	2 0.3×	3 0.4×	9	28
Evi Abada United States	5	17 0.6×	3 0.3×	4 0.5×	3 0.4×	17 2.4×	17	55
Marc Van den Bulcke Belgium	4	10 0.4×	12 1.3×	7 0.9×	2 0.3×	6 0.9×	13	50
Frederik Emil Juul Norway	5	50 1.9×	3 0.3×	9 1.1×	9 1.3×	10 1.4×	15	88
Sarah Quesnel-Crooks United States	2	30 1.1×	4 0.4×	6 0.8×	1 0.1×	6 0.9×	4	78

Countries citing papers authored by Elisa Biscaldi

Since Specialization

Citations

This map shows the geographic impact of Elisa Biscaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Biscaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Biscaldi more than expected).

Fields of papers citing papers by Elisa Biscaldi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Biscaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Biscaldi. The network helps show where Elisa Biscaldi may publish in the future.

Co-authorship network of co-authors of Elisa Biscaldi

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Biscaldi. A scholar is included among the top collaborators of Elisa Biscaldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Biscaldi. Elisa Biscaldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Albigès, Laurence, Robert J. Motzer, Ravindran Kanesvaran, et al.. (2025). Cabozantinib (C) in combination with nivolumab (N) and ipilimumab (I) in previously untreated advanced renal cell carcinoma (aRCC): Final results of COSMIC-313.. Journal of Clinical Oncology. 43(5_suppl). 438–438. 5 indexed citations

2.

Quaquarini, Erica, Daniele Presti, Valentina Tibollo, et al.. (2020). Impact of COVID-19 Outbreak on Cancer Patient Care and Treatment: Data from an Outpatient Oncology Clinic in Lombardy (Italy). Cancers. 12(10). 2941–2941. 27 indexed citations

3.

Porta, Camillo, Ilaria Imarisio, Mara De Amici, et al.. (2005). Pro-neoangiogenic cytokines (VEGF and bFGF) and anemia in solid tumor patients. Oncology Reports. 13(4). 689–95. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact